ACADIA Pharmaceuticals
ACAD
#3662
Rank
โ‚ฌ2.75 B
Marketcap
16,58ย โ‚ฌ
Share price
0.40%
Change (1 day)
-37.75%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): โ‚ฌ0.12 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.92 Billion. In 2023 the company made an earning of -โ‚ฌ48.61 Million, an increase over its 2022 earnings that were of -โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.12 B-356.73%
2023 -โ‚ฌ48.61 Million-76.09%
2022 -โ‚ฌ0.21 Billion27.41%
2021 -โ‚ฌ0.16 Billion-40.38%
2020 -โ‚ฌ0.27 Billion19.88%
2019 -โ‚ฌ0.23 Billion-3.92%
2018 -โ‚ฌ0.24 Billion-15.04%
2017 -โ‚ฌ0.28 Billion6.33%
2016 -โ‚ฌ0.26 Billion64.55%
2015 -โ‚ฌ0.16 Billion77.47%
2014 -โ‚ฌ88.08 Million143.69%
2013 -โ‚ฌ36.15 Million81.93%
2012 -โ‚ฌ19.87 Million-8.73%
2011 -โ‚ฌ21.77 Million-251.39%
2010 โ‚ฌ14.37 M-133.2%
2009 -โ‚ฌ43.31 Million-30.82%
2008 -โ‚ฌ62.6 Million6.43%
2007 -โ‚ฌ58.82 Million25.89%
2006 -โ‚ฌ46.72 Million36.99%
2005 -โ‚ฌ34.11 Million37.22%
2004 -โ‚ฌ24.86 Million19.96%
2003 -โ‚ฌ20.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ35.7 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.61 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.66 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.51 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.56 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ36.8 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA